|
Re: Merrill Lynch
|
6
|
Resverlogix Corp.
|
Jun 09, 2020 04:46PM
|
|
Re: Update from IR -- Eversana paused?
|
6
|
Resverlogix Corp.
|
Dec 22, 2022 12:15PM
|
|
Re: Prospects for resverlogix
|
6
|
Resverlogix Corp.
|
Jul 15, 2020 12:08PM
|
|
Re: MD&A out
|
6
|
Resverlogix Corp.
|
Dec 15, 2018 08:44AM
|
|
Re: Today's stream - link
|
6
|
Resverlogix Corp.
|
Sep 10, 2020 03:22PM
|
|
Re: If BP buys Apabetalone,...
|
6
|
Resverlogix Corp.
|
Nov 10, 2019 08:37AM
|
|
Re: ZHCLF
|
6
|
Zenith Epigenetics
|
Feb 08, 2024 10:46AM
|
|
Re: Covid and apabetalone
|
6
|
Resverlogix Corp.
|
Oct 21, 2020 07:40AM
|
|
Re: Big Pharm
|
6
|
Resverlogix Corp.
|
Oct 03, 2024 08:04AM
|
|
Re: eGFR and Cognition?
|
6
|
Resverlogix Corp.
|
Nov 23, 2019 06:16PM
|
|
Re: VOLUME
|
6
|
Resverlogix Corp.
|
Jun 30, 2021 12:40PM
|
|
Pfizer lays out ambitious vision for cancer portfolio in bid to reinvigorate its business.
|
6
|
Zenith Epigenetics
|
Mar 01, 2024 07:09PM
|
|
Re: Don's latest presentation - Pfizer's SGLT2 is Steglatro (Ertugliflozin)
|
6
|
Resverlogix Corp.
|
Sep 24, 2020 08:54AM
|
|
Re: Nonprofit Think Tank
|
6
|
Zenith Epigenetics
|
Oct 06, 2020 03:35PM
|
|
Re: Reports of exempt distribution on SEDAR
|
6
|
Resverlogix Corp.
|
Mar 29, 2018 10:41AM
|
|
Re: Resverlogix Announces Publication on Apabetalone in Cardiovascular Therapeutics
|
6
|
Resverlogix Corp.
|
Aug 04, 2020 09:09PM
|
|
Re: The Longer It Lasts, The Better It Is???
|
6
|
Resverlogix Corp.
|
Dec 20, 2015 05:19PM
|
|
Re: Resverlogix Announces Publication on Apabetalone in Cardiovascular Therapeutics
|
6
|
Resverlogix Corp.
|
Aug 04, 2020 09:21PM
|
|
Re: TD Zenith Capital Corp | Grey Market : ZHCLF
|
6
|
Zenith Epigenetics
|
Jul 15, 2020 03:31PM
|
|
Re: Zenith AGM
|
6
|
Zenith Epigenetics
|
Nov 24, 2023 09:41PM
|
